Research Article
Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients
Table 2
List of antibodies used in this study.
| Target | Antibody | Vendor | Cat # | Conjugated with |
| CD3 | SK7 | eBioscience | 46-0036-42 | PCp-eFluor-710 | CD14 | HCD14 | BioLegend | 325619 | APC-Cy7 | CD19 | HIB19 | BioLegend | 302217 | APC-Cy7 | CD16 | CB16 | eBioscience | 17-0168-41 | APC | CD56 | HD56 | BioLegend | 381310 | APC | CD16 | 3G8 | B&D | 302016 | PE-Cy7 | 2DL1 | HP-3E4 | B&D | 556062 | FITC | 2DL1/2DS1 | HP-MA4 | BioLegend | 339505 | PE | 2DL2/2DL3 | DX27 | BioLegend | 312605 | FITC | 2DL3 | 180701 | R&D | FAB2014F | PE/FITC | 2DS3 | — | LSBIO | LS-C165532 | Unconjugated | 2DL2/2DL3/2DS2 | GL183 | BC | IM2278U | PE | 2DL4 (CD158d) | mAB33/(33) | BioLegend | 347006 | PE | 2DS4 (CD158i) | JJC11.6 | MB | 130-092-680 | PE | 2DL5 (CD158f) | UP-R | BioLegend | 341303 | PE | 3DL1 | DX9 | B&D | 312706 | FITC | 3DL1/3DS1 | Z27 | BC | IM3292 | PE | 3DL2 (CD158k) | 539304 | R&D | FAB2878P | PE | NKG2A | 131411 | R&D | FAB1059 | PE | NKG2C | 134591 | R&D | FAB138P | PE | NKp46 | 9E2 | BioLegend | 331907 | PE | NKp44 | P44-8.1 | B&D | 558563 | PE | CD69 | FN50 | eBioscience | 11-0699-42 | FITC | VLA-4 (Iα4/CD49d) | 9F10 | eBioscience | 12-0499-42 | PE | Iβ7 | FIB27 | BioLegend | 121005 | PE | CD103 (IαE) | BecACT8 | BioLegend | 350206 | PE | IL-23R | 218213 | R&D | FAB14001P | PE | CD57 | HCD57 | BioLegend | 322306 | FITC | NKG2D | 1D11 | BioLegend | 320805 | PE | CXC3R1 | 2A9-1 | eBioscience | 12-6099-42 | PE |
|
|
B&D: Becton & Dickinson; LSBIO: Life Span Biotechnology; MB: Miltenyi Biotec; PCp: PerCP.
|